CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company
Passage BIO, Inc.
Sign in to watch- Ticker
- PASG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822729751
- Phone
- 2678660312
- Business address
- ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-18 | ORBIMED ADVISORS LLC 10% owner | Purchase | +114,700 | $5.46 | $626K | 6,222,323 |
| 2022-01-14 | ORBIMED ADVISORS LLC 10% owner | Purchase | +10,300 | $5.60 | $58K | 6,107,623 |
| 2022-01-13 | ORBIMED ADVISORS LLC 10% owner | Purchase | +41,800 | $5.52 | $231K | 6,097,323 |
| 2022-01-12 | ORBIMED ADVISORS LLC 10% owner | Purchase | +100,000 | $5.65 | $565K | 6,055,523 |
| 2022-01-11 | ORBIMED ADVISORS LLC 10% owner | Purchase | +8,200 | $5.53 | $45K | 5,955,523 |
| 2021-12-08 | Quigley Jill M. Chief Operating Officer | Option exercise | +71,975 | $0.23 | $17K | 368,754 |
| 2021-12-08 | Quigley Jill M. Chief Operating Officer | Option exercise · Employee Stock Option (right to buy) | −11,193 | 3,729 | ||
| 2021-12-08 | Quigley Jill M. Chief Operating Officer | Option exercise · Employee Stock Option (right to buy) | −60,782 | 27,626 | ||
| 2021-08-23 | King Simona Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +360,000 | 360,000 | ||
| 2021-08-16 | Forman Mark S CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2021-07-19 | Toernsen Monika Maria Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2021-07-19 | Toernsen Monika Maria Chief Commercial Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2021-05-27 | GOWEN MAXINE Director | Grant or award · Director Stock Option (Right to Buy) | +4,542 | 4,542 | ||
| 2021-05-27 | Woiwode Thomas Director | Grant or award · Director Stock Option (Right to Buy) | +16,918 | 16,918 | ||
| 2021-05-27 | Yamada Tadataka Director | Grant or award · Director Stock Option (Right to Buy) | +16,918 | 16,918 | ||
| 2021-05-27 | Islam Saqib Director | Grant or award · Director Stock Option (Right to Buy) | +16,918 | 16,918 | ||
| 2021-05-27 | Kapadia Sandip Director | Grant or award · Director Stock Option (Right to Buy) | +16,918 | 16,918 | ||
| 2021-05-27 | Ratcliffe Liam Director | Grant or award · Director Stock Option (Right to Buy) | +16,918 | 16,918 | ||
| 2021-05-27 | Porter Derrell Director | Grant or award · Director Stock Option (Right to Buy) | +33,836 | 33,836 | ||
| 2021-05-27 | Countouriotis Athena Director | Grant or award · Director Stock Option (Right to Buy) | +16,918 | 16,918 |
Page 9 of 14 · 264 trades